EBLN1
geneOn this page
Summary
EBLN1 (endogenous Bornavirus like nucleoprotein 1, HGNC:39430) is a protein-coding gene on chromosome 10p12.31, encoding Endogenous Bornavirus-like nucleoprotein 1 (P0CF75). May act as an RNA-binding protein.
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 56 total
- MANE Select transcript:
NM_001394757
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:39430 |
| Approved symbol | EBLN1 |
| Name | endogenous Bornavirus like nucleoprotein 1 |
| Location | 10p12.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000223601 |
| Ensembl biotype | protein_coding |
| OMIM | 613249 |
| Entrez | 340900 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000422359, ENST00000939589
RefSeq mRNA: 2 — MANE Select: NM_001394757
NM_001199938, NM_001394757
CCDS: CCDS60498
Canonical transcript exons
ENST00000422359 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001764833 | 22208475 | 22210027 |
| ENSE00003924445 | 22217916 | 22218015 |
| ENSE00003935864 | 22212842 | 22212965 |
Expression profiles
Bgee: expression breadth tissue_specific, 7 present calls, max score 96.65.
Top tissues by expression
101 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 96.65 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.81 | gold quality |
| right testis | UBERON:0004534 | 59.02 | gold quality |
| testis | UBERON:0000473 | 58.33 | gold quality |
| left testis | UBERON:0004533 | 58.30 | gold quality |
| granulocyte | CL:0000094 | 39.85 | gold quality |
| bone marrow cell | CL:0002092 | 38.50 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| mucosa of stomach | UBERON:0001199 | 35.85 | silver quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| bone marrow | UBERON:0002371 | 34.19 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| ectocervix | UBERON:0012249 | 31.99 | gold quality |
| uterine cervix | UBERON:0000002 | 31.74 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 30.90 | silver quality |
| fallopian tube | UBERON:0003889 | 30.42 | gold quality |
| right uterine tube | UBERON:0001302 | 30.25 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| substantia nigra | UBERON:0002038 | 29.75 | silver quality |
| left uterine tube | UBERON:0001303 | 29.57 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 29.04 | gold quality |
| leukocyte | CL:0000738 | 28.90 | gold quality |
| myometrium | UBERON:0001296 | 28.71 | gold quality |
| liver | UBERON:0002107 | 28.32 | gold quality |
| monocyte | CL:0000576 | 28.29 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| islet of Langerhans | UBERON:0000006 | 28.09 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.80 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- Our results provide evidence for new loci influencing abdominal visceral (BBS9, ADCY8, KCNK9) and subcutaneous (MLLT10/DNAJC1/EBLN1) fat, and confirmed a locus (THNSL2) previously reported to be associated with abdominal fat in women. (PMID:26480920)
- Numerous genes were dysregulated by Endogenous bornavirus-like nucleoprotein 1 silencing, some of which may be key target genes of Rho family GTPase 3, oncostatin M receptor, and cAMP responsive element binding protein 3-like 2 protein. (PMID:27023521)
- human EBLN1 possesses important cellular functions within human cells. (PMID:27739501)
Cross-species orthologs
0 orthologs
Paralogs (1): EBLN2 (ENSG00000255423)
Protein
Protein identifiers
Endogenous Bornavirus-like nucleoprotein 1 — P0CF75 (reviewed: P0CF75)
Alternative names: Endogenous Borna-like N element-1
All UniProt accessions (1): P0CF75
UniProt curated annotations — full annotation on UniProt →
Function. May act as an RNA-binding protein. Highly homologous to the bornavirus nucleocapsid N protein that binds viral RNA and oligomerizes.
Tissue specificity. Expression detected by RT-PCR in a few cell lines, including OL, HEK293T and MOLT-4. Not observed in HeLa cells.
Miscellaneous. Bornavirus is a non-retroviral RNA virus that does not generate DNA forms during viral replication. Therefore, integration of EBLN-1 must have occur through a mechanism relying on an endogenous reverse transcriptase activity.
RefSeq proteins (2): NP_001186867, NP_001381686* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009441 | P40_nucleoprot_BD-vir | Family |
| IPR015969 | P40_nucleoprot_sub1_BD-vir | Homologous_superfamily |
| IPR015970 | P40_nucleoprot_sub2_BD-vir | Homologous_superfamily |
| IPR036260 | P40_nucleoprot_sf_BD-vir | Homologous_superfamily |
Pfam: PF06407
UniProt features (5 total): sequence conflict 2, chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0CF75-F1 | 84.45 | 0.61 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 3 (showing top):
chr10p12, PAX3_TARGET_GENES, SUPT16H_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
150 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EBLN1 | LIME1 | Q9H400 | 518 |
| EBLN1 | C16orf96 | A6NNT2 | 505 |
| EBLN1 | AP1S1 | P61966 | 493 |
| EBLN1 | FAM194C | Q8ND61 | 479 |
| EBLN1 | ZNF284 | Q2VY69 | 476 |
| EBLN1 | FANCC | Q00597 | 413 |
| EBLN1 | YAE1 | Q9NRH1 | 400 |
| EBLN1 | LRRC46 | Q96FV0 | 377 |
| EBLN1 | MYCBPAP | Q8TBZ2 | 370 |
| EBLN1 | KRTAP2-3 | P0C7H8 | 353 |
| EBLN1 | V9GYV3 | V9GYV3 | 353 |
| EBLN1 | ETNK1 | Q9HBU6 | 348 |
| EBLN1 | GPR45 | Q9Y5Y3 | 325 |
| EBLN1 | TLL2 | Q9Y6L7 | 311 |
| EBLN1 | WDR46 | O15213 | 308 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EBLN1 | TTN | psi-mi:“MI:0915”(physical association) | 0.400 |
| EBLN1 | STAG2 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (3): EBLN1 (Affinity Capture-MS), STAG2 (Proximity Label-MS), TTN (Proximity Label-MS)
ESM2 similar proteins: A0A345BJN9, A1XFV8, A3DRP6, A3RM21, A7WNB1, A8C8K0, B2ZCQ0, F5HDY6, P03499, P04858, P07051, P08593, P08671, P09280, P0C772, P0C773, P0CF75, P0DOE1, P13140, P14155, P21431, P22046, P31964, P47146, P52510, Q00151, Q04551, Q07458, Q07FH9, Q0GBY2, Q197F9, Q1I0U5, Q289M1, Q5K2K5, Q5NDN1, Q65YU7, Q6P5S2, Q6XSW4, Q6XTD8, Q6XTK0
Diamond homologs: P0C796, P0C797, P0CF75, Q6P2I7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
56 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 54 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
193 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:22209350:C:CT | acceptor_gain | 0.6800 |
| 10:22209484:G:A | donor_gain | 0.6100 |
| 10:22209447:TTC:T | donor_gain | 0.5600 |
| 10:22209080:C:CC | acceptor_gain | 0.5500 |
| 10:22209161:GTACC:G | donor_loss | 0.5100 |
| 10:22209162:TACC:T | donor_loss | 0.5100 |
| 10:22209163:A:AC | donor_gain | 0.5100 |
| 10:22209163:ACCTT:A | donor_loss | 0.5100 |
| 10:22209164:C:CC | donor_gain | 0.5100 |
| 10:22209164:C:CG | donor_loss | 0.5100 |
| 10:22209349:C:G | acceptor_gain | 0.5100 |
| 10:22209032:C:CT | acceptor_gain | 0.4900 |
| 10:22208973:C:CT | acceptor_gain | 0.4800 |
| 10:22209261:T:A | donor_gain | 0.4800 |
| 10:22208976:T:C | acceptor_gain | 0.4600 |
| 10:22209351:A:T | acceptor_gain | 0.4600 |
| 10:22209079:GCT:G | acceptor_gain | 0.4500 |
| 10:22209163:AC:A | donor_gain | 0.4500 |
| 10:22209164:CC:C | donor_gain | 0.4500 |
| 10:22209350:C:T | acceptor_gain | 0.4500 |
| 10:22209448:T:A | donor_gain | 0.4500 |
| 10:22209465:T:TA | donor_gain | 0.4500 |
| 10:22209206:C:G | acceptor_gain | 0.4400 |
| 10:22209077:TTG:T | acceptor_gain | 0.4300 |
| 10:22208981:G:GC | acceptor_gain | 0.4200 |
| 10:22209080:C:A | acceptor_gain | 0.4200 |
| 10:22209205:T:TG | acceptor_gain | 0.4100 |
| 10:22209033:A:T | acceptor_gain | 0.4000 |
| 10:22209076:GTTGC:G | acceptor_gain | 0.4000 |
| 10:22209077:TTGCT:T | acceptor_gain | 0.4000 |
AlphaMissense
2420 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:22209090:G:C | F298L | 0.932 |
| 10:22209090:G:T | F298L | 0.932 |
| 10:22209092:A:G | F298L | 0.932 |
| 10:22209741:A:C | F81L | 0.922 |
| 10:22209741:A:T | F81L | 0.922 |
| 10:22209743:A:G | F81L | 0.922 |
| 10:22209255:G:C | F243L | 0.902 |
| 10:22209255:G:T | F243L | 0.902 |
| 10:22209257:A:G | F243L | 0.902 |
| 10:22209768:A:C | F72L | 0.897 |
| 10:22209768:A:T | F72L | 0.897 |
| 10:22209770:A:G | F72L | 0.897 |
| 10:22209192:A:C | F264L | 0.874 |
| 10:22209192:A:T | F264L | 0.874 |
| 10:22209194:A:G | F264L | 0.874 |
| 10:22209489:G:C | F165L | 0.873 |
| 10:22209489:G:T | F165L | 0.873 |
| 10:22209491:A:G | F165L | 0.873 |
| 10:22209027:A:C | F319L | 0.869 |
| 10:22209027:A:T | F319L | 0.869 |
| 10:22209029:A:G | F319L | 0.869 |
| 10:22209894:A:C | F30L | 0.864 |
| 10:22209894:A:T | F30L | 0.864 |
| 10:22209896:A:G | F30L | 0.864 |
| 10:22209342:A:C | F214L | 0.856 |
| 10:22209342:A:T | F214L | 0.856 |
| 10:22209344:A:G | F214L | 0.856 |
| 10:22209036:A:C | F316L | 0.854 |
| 10:22209036:A:T | F316L | 0.854 |
| 10:22209038:A:G | F316L | 0.854 |
dbSNP variants (sampled 300 via entrez): RS1000350251 (10:22210331 A>G), RS1000834713 (10:22215093 T>C), RS1001448761 (10:22210680 T>C), RS1001853304 (10:22208911 C>A,G,T), RS1001870101 (10:22215168 A>G), RS1001919703 (10:22210355 T>C), RS1001962018 (10:22217931 G>A), RS1002566736 (10:22208424 G>C), RS1002671631 (10:22217764 A>C), RS1003046846 (10:22211464 A>T), RS1003195834 (10:22208090 G>A,T), RS1003212263 (10:22219281 C>T), RS1003226317 (10:22212867 T>C), RS1003737828 (10:22219698 G>A), RS1003902965 (10:22215686 G>A,T)
Disease associations
OMIM: gene MIM:613249 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003170_7 | Subcutaneous adipose tissue | 4.000000e-08 |
| GCST007327_95 | Smoking status (ever vs never smokers) | 1.000000e-09 |
| GCST007507_12 | Benign prostatic hyperplasia and lower urinary tract symptoms | 2.000000e-15 |
| GCST010136_13 | Fruit consumption | 1.000000e-08 |
| GCST010136_20 | Fruit consumption | 3.000000e-08 |
| GCST010136_26 | Fruit consumption | 5.000000e-20 |
| GCST010142_85 | Fish- and plant-related diet | 2.000000e-24 |
| GCST011351_16 | Aspartate aminotransferase levels | 2.000000e-09 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004318 | smoking behavior |
| EFO:0008008 | lower urinary tract symptom |
| EFO:0008111 | diet measurement |
| EFO:0004736 | aspartate aminotransferase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| abrine | increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): benign prostatic hyperplasia